Royalty Pharma (RPRXN) Q2 2022 Earnings Report
MX:RPRXN Q2 2022 EPS Results
- Actual EPS
- MXN 15.07
- Consensus EPS
- MXN 14.51
- Beat/Miss
- Beat by +MXN 0.56
- One Year Ago EPS
- MXN 13.51
MX:RPRXN Q2 2022 Revenue Results
- Actual Revenue
- MXN 9.96B
- Expected Revenue
- MXN 9.82B
- Beat/Miss
- Beat by +MXN 141.08M
- YoY Revenue Growth
- -3.43%
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 08/04/2022
- Time
- Before Open
- Conference Call
- Thursday, August 4, 2022
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:RPRXN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 04, 2026 | 2026 (Q3) | 21.94- | 21.8 | ― | |
| Aug 05, 2026 | 2026 (Q2) | 23.6524.55 | 21.2 | 15.78% (+3.34) | |
| May 06, 2026 | 2026 (Q1) | 22.5624.08 | 13.92 | 73.03% (+10.16) | |
| Feb 11, 2026 | 2025 (Q4) | 23.8927.24 | 21.39 | 27.37% (+5.85) | |
| Nov 05, 2025 | 2025 (Q3) | 18.4721.80 | 17.04 | 27.92% (+4.76) | |
| Aug 06, 2025 | 2025 (Q2) | 19.1821.20 | 17.86 | 18.73% (+3.34) | |
| May 08, 2025 | 2025 (Q1) | 17.7113.92 | 18.17 | -23.42% (-4.26) | |
| Feb 11, 2025 | 2024 (Q4) | 19.6021.39 | 21.35 | 0.17% (+0.04) | |
| Nov 06, 2024 | 2024 (Q3) | 17.2217.04 | 14.66 | 16.22% (+2.38) | |
| Aug 08, 2024 | 2024 (Q2) | 17.9317.86 | 15.7 | 13.73% (+2.16) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
